Is chronic plaque psoriasis triggered by microbiota in the skin?

British Journal of Dermatology

Volumn 169, Issue 1, 2013, Pages 47-52

  Fry, L ^a   Baker, B S ^b   Powles, A V ^a   Fahlen, A ^b   Engstrand, L ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 23; NITRIC OXIDE SYNTHASE; PEPTIDOGLYCAN RECOGNITION PROTEIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; USTEKINUMAB; BACTERIAL PROTEIN; CELL SURFACE RECEPTOR; PEPTIDOGLYCAN RECEPTOR; TOLL LIKE RECEPTOR;

COMMENSAL; FIRMICUTES; GENE MUTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; INCIDENCE; INNATE IMMUNITY; KERATINOCYTE; LANGERHANS CELL; MACROPHAGE; MAST CELL; MONOCYTE; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PERIODONTITIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; REVIEW; SKIN FLORA; STREPTOCOCCUS; TH17 CELL; BACTERIAL SKIN DISEASE; CHRONIC DISEASE; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

BACTERIAL PROTEINS; CHRONIC DISEASE; HUMANS; IMMUNITY, INNATE; MICROBIOTA; PSORIASIS; RECEPTORS, CELL SURFACE; SKIN DISEASES, BACTERIAL; TOLL-LIKE RECEPTORS;

EID: 84879930487     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12322     Document Type: Review

References (61)

1. Yates VM, Watkinson G, Kelman A,. Further evidence of an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol 1982; 106: 323-30.
2. Hughes S, Williams SE, Turnberg RA,. Crohn's disease and psoriasis. N Engl J Med 1983; 308: 101.
3. Lee FI, Bellary SV, Francis C,. Increased incidence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1990; 85: 962-3.
4. Nair RP, Henseler T, Jenisch S, et al,. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997; 6: 1349-56.
5. Li WQ, Han JL, Chan AT, Qureshi AA,. Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in U.S. women. Ann Rheum Dis 2013; doi: 10.1136/annrheumdis-2012-202143.
6. Bjarnason I, O'Morain C, Levi AJ, Peters TJ,. Absorption of 51-chromium-labelled ethylenediamine tetraacetate in inflammatory bowel disease. Gastroenterology 1983; 85: 318-22.
7. Peeters M, Ghoos Y, Maes B, et al,. Increased permeability of macroscopically normal small bowel in Crohn's disease. Dig Dis Sci 1994; 39: 2170-6.
8. Hollander D, Vadheim CM, Brettholz E, et al,. Increased intestinal permeability in patients with Crohn's disease and their relatives: a possible aetiological factor. Ann Intern Med 1986; 105: 883-5.
9. Ojetti V, De Simone C, Aguilar Sanchez JA, et al,. Malabsorption in psoriatic patients: cause or effect. Scand J Gastroenterol 2006; 41: 1267-71.
10. Hedin CR, Stagg AJ, Whelan K, Lindsay JO,. Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention. Gut 2012; 61: 311-18.
11. Willing BP, Dicksved J, Halfvarson J, et al,. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139: 1844-54.
12. Joossens M, Huys G, Cnockaert M, et al,. Dysbiosis of faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60: 631-7.
13. Preus HR, Khanifam P, Kolltveit K, et al,. Periodontitis in psoriasis patients: a blinded case controlled study. Acta Odontol Scand 2010; 68: 165-70.
14. Radcliffe Crocker H,. Diseases of the Skin. London: HK Lewis, 1893.
15. Unna PC,. Histopathology of the Diseases of the Skin. New York: Macmillan & Co., 1896.
16. Gao Z, Tseng CH, Strober BE, et al,. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS ONE 2008; 3: e2719.
17. Fahlén A, Engstrand L, Baker BS, et al,. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res 2012; 304: 15-22.
18. Nakatsuji T, Chiang HI, Jiang SB, et al,. The microbiome extends to subepidermal compartments of normal skin. Nat Commun 2013; 4: 1431.
19. Grice EA, Kong HH, Conlan S, et al,. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324: 1190-2.
20. Paulino LC, Tseng CH, Strober BE, Blaser MJ,. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J Clin Microbiol 2006; 44: 2933-41.
21. Paulino LC, Tseng CH, Blaser MJ,. Analysis of Malassezia microbiota in healthy superficial human skin and in psoriatic lesions by multiplex real-time PCR. FEMS Yeast Res 2008; 8: 460-71.
22. Lomholt G,. Psoriasis, Prevalence, Spontaneous Course and Genetics. Copenhagen: G.E.C. Gad, 1963.
23. Hellgren L,. Psoriasis. Stockholm: Almqvist and Wiksell, 1967.
24. Bandrup F, Hauge M, Henningsen K, Eriksen B,. Psoriasis in an unselected series of twins. Arch Dermatol 1978; 114: 874-8.
25. Capon F, Burden AD, Trembath RC, Barker JN,. Psoriasis and other complex trait dermatoses: from loci to functional pathways. J Invest Dermatol 2012; 132: 915-22.
26. Hébert HL, Ali FR, Bowes J, et al,. Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy. Br J Dermatol 2012; 166: 474-82.
27. Franke A, McGovern DP, Barrett JC, et al,. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42: 1118-25.
28. Park JH, Wacholder S, Gail MH, et al,. Estimation of effect of size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 2010; 42: 570-5.
29. Tsoi LC, Spain SL, Knight J, et al,. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012; 44: 1341-8.
30. Baker BS, Laman JD, Powles AV, et al,. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions. J Pathol 2006; 209: 174-81.
31. Baker BS, Powles AV, Fry L,. Peptidoglycan: a major aetiological factor for psoriasis? Trends Immunol 2006; 27: 545-51.
32. Capon F, Semprini S, Chimenti S, et al,. Fine mapping of PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol 2001; 116: 728-30.
33. Sun C, Mathur P, Dupuis J, et al,. Peptidoglycan recognition proteins Pglyrp3 and Pglyrp4 are encoded from the epidermal differentiation complex and are candidate genes for the Psors4 locus on chromosome 1q21. Hum Genet 2006; 119: 113-25.
34. Kainu K, Kivinen K, Zucchelli M, et al,. Association of psoriasis to PGLYRP and SPRR genes at PSORS4 locus on 1q shows heterogeneity between Finnish, Swedish and Irish families. Exp Dermatol 2009; 18: 109-15.
35. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al,. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-3.
36. Plant D, Lear J, Marsland A, et al,. CARD15/NOD2 single nucleotide polymorphisms do not confer susceptibility to type 1 psoriasis. Br J Dermatol 2004; 151: 675-8.
37. Jordan CT, Cao L, Roberson ED, et al,. PSORS2 is due to mutations in CARD14. Am J Hum Genet 2012; 90: 784-95.
38. Sweeney CM, Tobin AM, Kirby B,. Innate immunity in the pathogenesis of psoriasis. Arch Dermatol Res 2011; 303: 691-705.
39. Marks DJ, Harbord MW, MacAllister R, et al,. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006; 367: 668-78.
40. Sartor RB,. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-94.
41. Jarchum I, Pamer EG,. Regulation of innate and adaptive immunity by the commensal microbiota. Curr Opin Immunol 2011; 23: 353-60.
42. Tonel G, Conrad C, Laggner U, et al,. Cutting edge: a critical functional role for IL-23 in psoriasis. J Immunol 2010; 185: 5688-91.
43. Park H, Li Z, Xang XO, et al,. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-41.
44. Lowes MA, Kikuchi T, Fuentes-Duculan J, et al,. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128: 1207-11.
45. Kimball AB, Papp KA, Wasfi Y, et al,. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study. J Eur Acad Dermatol Venereol 2012; doi: 10.1111/jdv.12046.
46. Morizane S, Gallo RL,. Antimicrobial peptides in the pathogenesis of psoriasis. J Dermatol 2012; 39: 225-30.
47. Harder J, Schröder JM,. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 2005; 77: 476-86.
48. Ong PY, Ohtake T, Brandt C, et al,. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-60.
49. Baker BS, Ovigne JM, Powles AV, et al,. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2, and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 2003; 148: 670-9.
50. Yoshimura A, Lien E, Ingalls RR, et al,. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1-5.
51. Lien E, Sellati TJ, Yoshimura A, et al,. Toll like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274: 33419-25.
52. Brightbill HD, Libraty DH, Krutzik SR, et al,. Host defence mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285: 732-6.
53. Poltorak A, He X, Smirnova I, et al,. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-8.
54. Qureshi ST, Larivière L, Leveque G, et al,. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 615-25.
55. Dziarski R, Gupta D,. Review: mammalian peptidoglycan recognition proteins (PGRPs) in innate immunity. Innate Immun 2010; 16: 168-74.
56. Valdimarsson H, Baker BS, Jonsdottir I, Fry L,. Psoriasis a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 1986; 7: 256-9.
57. Munz OH, Sela S, Baker BS, et al,. Evidence for the presence of bacteria in the blood of psoriasis patients. Arch Dermatol Res 2010; 302: 495-8.
58. Peslyak M,. Model of Pathogenesis of Psoriasis. Part 1. Systemic Psoriatic Process, Edition e3.2. Moscow: Nabu Press, 2012.
59. McGovern D, Powrie F,. The IL-23 axis plays a key role in the pathogenesis of IBD. Gut 2007; 56: 1333-6.
60. Brand S,. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009; 58: 1152-67.
61. Danese S,. New therapies for inflammatory bowel disease: from the bench to the bedside. Gut 2012; 61: 918-32.